COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2770: Articles 27691-27700  | Next

Empirical Assessment of COVID-19 Crisis Standards of Care Guidelines
Jezmir, J. L., Bharadwaj, M., Kishore, S. P., Winkler, M., Diephuis, B., Kim, E. Y., Feldman, W. B.
10.1101/2020.05.16.20098657 — Posted: 2020-05-19
Reciprocal association between participation to a national election and the epidemic spread of COVID-19 in France: nationwide observational and dynamic modeling study.
Zeitoun, J.-D., Faron, M., Manternach, s., Fourquet, J., Lavielle, M., lefevre, j.
10.1101/2020.05.14.20090100 — Posted: 2020-05-19
Human IgG cell neutralizing monoclonal antibodies block SARS-CoV-2 infection
Lan, F., Xu, J., Lu, Y., Wan, J., Xing, S., Wang, Y., Ding, L., Yuan, S., Qiu, C., Zhao, C., Zhang, X., Wang, X.
10.1101/2020.05.19.104117 — Posted: 2020-05-19 Discussion: Onsite
Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate
Arora, K., Rastogi, R., Arora, N. M., Parashar, D., Paliwal, J., Naqvi, A., Srivastava, A., Singh, S. K., Kalyanaraman, S., Potdar, S., Kumar, D., Arya, V. B., Bansal, S., Rautray, S., Singh, I., Fengade, P. S., Kumar, B., Kundu, P. K.
10.1101/2020.05.18.099234 — Posted: 2020-05-19
Antiviral activity of Glucosylceramide synthase inhibitors against SARS-CoV-2 and other RNA virus infections
Vitner, E. B., Avraham, R., Achdout, H., Tamir, H., Agami, A., Cherry, L., Yahalom-Ronen, Y., Politi, B., Erez, N., Melamed, S., Paran, N., Israely, T.
10.1101/2020.05.18.103283 — Posted: 2020-05-19
The impact of super-spreaders in COVID-19: mapping genome variation worldwide
Gomez-Carballa, A., Bello, X., Pardo-Seco, J., Martinon-Torres, F., Salas, A.
10.1101/2020.05.19.097410 — Posted: 2020-05-19
Emerging phylogenetic structure of the SARS-CoV-2 pandemic
Fountain-Jones, N. M., Carol Appaw, R., Carver, S., Didelot, X., Volz, E. M., Charleston, M.
10.1101/2020.05.19.103846 — Posted: 2020-05-19
High Throughput Designing and Mutational Mapping of RBD-ACE2 Interface Guide Non-Conventional Therapeutic Strategies for COVID-19
Padhi, A. K., Kalita, P., Zhang, K. Y. J., Tripathi, T.
10.1101/2020.05.19.104042 — Posted: 2020-05-19
Transcriptional profiling of immune and inflammatory responses in the context of SARS-CoV-2 fungal superinfection in a human airway epithelial model
Nicolas de Lamballerie, C., Pizzorno, A., Fouret, J., szpiro, L., Padey, B., Dubois, J., Julien, T., Traversier, A., Duliere, V., Brun, P., Lina, B., Rosa-Calatrava, M., Terrier, O.
10.1101/2020.05.19.103630 — Posted: 2020-05-19 Discussion: Onsite | Offsite
log(x+1)* and log(1+x)
Booeshaghi, A. S., Pachter, L.
10.1101/2020.05.19.100214 — Posted: 2020-05-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).